Eagle's Eye View: Your Weekly CV Update From ACC.org
By American College of Cardiology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by American College of Cardiology
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 24
Reviews: 0
Episodes: 100
Description
The weekly cardiovascular update from Kim Eagle, MD, MACC for ACC.org covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.
| Episode | Date |
|---|---|
|
Carvedilol To Treat HFimpEF; Modifiable Lifestyle Factors & Cardiac Conduction Disease; Amiloride vs. Spironolactone for Resistant Hypertension
|
May 28, 2025 |
|
Colchicine vs. Placebo in Reducing CV Events; DOACs vs. Warfarin After TAVR; CSP vs. BiVP and Echo Response
|
May 21, 2025 |
|
ORBITA-2 & PCI; Blood Pressure Control & Increasing Medication Prescriptions; Rapid Initiation & Titration in GRMT for Patients with HFrEF
|
May 14, 2025 |
|
Lp(a) and CV Risk; CRP Levels and High-Risk Vulnerable Plaque post-NSTEMI; Pulsed Field Ablation vs. Cryoablation for Paroxysmal AFib
|
Apr 30, 2025 |
|
Weight Management in Pregnancy and CVD Risk; Impact of Statins Plus Ezetimibe Post-MI; PARTNER-3 Study 5-year Results
|
Apr 23, 2025 |
|
Outcomes of Pre-ablation Transesophageal Echocardiograms; TAVI vs. SAVR in Women With Severe AS; Effects in the Use of Oral Anti-coagulants (OACs)
|
Apr 16, 2025 |
|
Key Takeaways from ACC.25 Major Trials and Presentations
|
Apr 02, 2025 |
|
Cardiogenic Shock Guidance; Mortality after Mitral Repair & TAVR; Direct-to-Physician Marketing Affects GDMT
|
Mar 26, 2025 |
|
Smoking & CVD Risk; Sleep, Diabetes, & Women with Gestational Diabetes; Post-TAVR Imaging
|
Mar 19, 2025 |
|
Short-term DAPT, PCI & High Bleeding Risk; Dapagliflozin & Heart Failure; Non-Pharmacologic Treatment of HF
|
Mar 12, 2025 |
|
Identifying Myocardial Infarction after PCI; Myocardial Fibrosis & Severe Aortic Valve Stenosis; Anticoagulation & Cancer Diagnoses
|
Mar 05, 2025 |
|
SGLT2 Inhibitors & Aortic Valve Stenosis; Early vs. Later Ablation for Afib; Sports Participation by Athletes with Cardiac Abnormalities
|
Feb 26, 2025 |
|
Arrhythmia Recurrence & Rhythm Control after Catheter Ablation for AFib; Transthyretin Amyloid Cardiomyopathy & Tafamidis; Sodium Restriction & BP
|
Feb 19, 2025 |
|
Blood Pressure & Postpartum; Beta Blockers & Takotsubo Syndrome; Secondary Prevention Worldwide
|
Feb 12, 2025 |
|
Cardiac Rehab & Heart Failure, CV Care & Cancer Survivors, Bioprosthetic AVR vs Mechanical AVR in Younger Patients
|
Feb 05, 2025 |
|
Cost-effectiveness of Polypills, Obesity and FH, Adverse Pregnancy Outcomes and Long-term HF Risk
|
Jan 29, 2025 |
|
Left Atrial Appendage Occlusion & Stroke, Hypertrophic Cardiomyopathy in Children, Anticoagulation & COVID-19
|
Jan 22, 2025 |
|
Top Trials, Journal Scans, and Takeaways of 2024
|
Dec 23, 2024 |
|
What Cardiologists Should Know About Congenital Heart Disease, Cardiac Arrest and Death in Athletes, Arrhythmia After Stroke
|
Dec 18, 2024 |
|
Management of Myocarditis; Sex Differences in PCI vs. CABG; RVOT Dysfunction in Repaired TOF
|
Dec 11, 2024 |
|
Compression Tights in Patients With POTS, Platelet Function and Genetic Testing in PCI, Aspirin in Stent Patients Undergoing Noncardiac Surgery
|
Dec 04, 2024 |
|
Prevalence of U.S. Overweight and Obesity, Consensus on CPR, Bleeding Risk Using NSAIDs With Anticoagulants
|
Nov 27, 2024 |
|
Top Six Trials From AHA 2024: BROAD, SUMMIT, OPTION, CLEAR SYNERGY (Spironolactone and Colchicine), My Heart Your Heart
|
Nov 21, 2024 |
|
Top Six Trials From AHA 2024: BROAD, SUMMIT, OPTION, CLEAR SYNERGY (Spironolactone and Colchicine), My Heart Your Heart
|
Nov 21, 2024 |
|
Exercise Training in HCM; Management of Kawasaki Disease; Race, Social Determinants of Health, Polygenic Risk for CHD
|
Nov 20, 2024 |
|
Transseptal Mitral Valve-in-Valve Procedure, Complete vs. Culprit-Only Revascularization in Older Patients, Hypertensive Pregnancy and MI Risk
|
Nov 13, 2024 |
|
TAVR in Younger Patients; Atorvastatin vs. Rosuvastatin; Sedentary Behavior and Blood Pressure
|
Nov 06, 2024 |
|
Top Four Trials from TCT 2024: EARLY TAVR, TRISCEND II for Tricuspid Regurgitation, ECLIPSE on orbital atherectomy, and CLEAR SYNERGY (OASIS 9) & colchicine treatment
|
Nov 05, 2024 |
|
Discontinuing Drug Treatment in HFrEF, Race and Sacubitril/Valsartan Use in HF, Systolic BP Polygenic Risk Score Treatment Responses
|
Oct 30, 2024 |
|
Real-time AI to Influence Clinical Decisions and Practice Towards Evidence-based Care: RAPIDxAI Trial
|
Oct 29, 2024 |
|
Anthracycline Cardiotoxicity in Cancer Patients; Arrhythmias, Autonomic Dysfunction and COVID-19; Lowering Non–HDL Cholesterol After MI
|
Oct 23, 2024 |
|
Semaglutide and BP, HF Risk Assessment Using Biomarkers, DAPT After Drug-Eluting Stenting in ACS
|
Oct 16, 2024 |
|
CV Events After COVID Vaccine, Septal Reduction in Obstructive HCM, Acute Pulmonary Embolism Guideline Comparison
|
Oct 09, 2024 |
|
Hospital Survival After AAA Repair, Myocardial Fibrosis and Aortic Stenosis, MRA Use in HF
|
Oct 02, 2024 |
|
Risk Stratification in Nonischemic Dilated Cardiomyopathy, 2024 Guideline for Perioperative CV Management for Noncardiac Surgery, Lipoprotein(a) and Cardiovascular Disease
|
Sep 25, 2024 |
|
Long-Term Outcomes in Pericarditis, Polygenic Risk Score and Predicting CVD, Aortic Disease in Children with FBN1-Related Marfan Syndrome
|
Sep 18, 2024 |
|
Eight Practice-Changing Trials Featured at ESC Congress 2024
|
Sep 12, 2024 |
|
Mechanical Circulatory Support in Infarct-Related Cardiogenic Shock, Anticoagulation Benefit in Device-Detected AFib, Semaglutide in HFpEF Patients
|
Sep 11, 2024 |
|
SGLT2 Inhibitors vs. GLP-1 RAs in Diabetes, MRI Lesions After TAVR, Perioperative Management and Anticoagulants
|
Sep 04, 2024 |
|
Social Determinants of Health in Cardiology, Aortopathy in Children, Cardiac CT Following Left Atrial Appendage Occlusion
|
Aug 28, 2024 |
|
Genetics and Risk in Aortic Disease, Plant vs. Animal Fat in Cardiovascular Outcomes, Management of Cardiac Sarcoidosis
|
Aug 21, 2024 |
|
Update to ACC/AHA Heart Failure Performance Measures; Quadruple Therapy and HF; ACEi, ARBs, and Chronic Kidney Disease
|
Aug 14, 2024 |
|
Pulmonary Hypertension and HF, Obesity in Adolescents, Noncardiac Surgery After TAVR
|
Aug 07, 2024 |
|
Fenestrated-Branched Endovascular Aortic Repair, Mortality and PCI, Lp(a) and Calcific Aortic Stenosis Progression
|
Jul 31, 2024 |
|
Diuretics and HF, Implantable Cardioverter-Defibrillators and the Tricuspid Valve and Right Ventricle, Neurohormonal Blockade and HF
|
Jul 24, 2024 |
|
Racial Differences in Diabetic Cardiomyopathy, Genetics of HCM, Semaglutide vs. Tirzepatide for Weight Loss
|
Jul 17, 2024 |
|
Iron Repletion and Heart Failure, Ventricular Septal Defect and Acute Myocardial Infarction, Hemodynamic Assessment for HF
|
Jul 10, 2024 |
|
Early Rhythm Control, Low-Dose Aspirin and Prevention, Autoimmune Diseases and Atherosclerosis
|
Jul 02, 2024 |
|
In-office and At-Home Blood Pressure Measurement, Artificial Intelligence and Cardiovascular Care, Inflammatory Risk
|
Jun 26, 2024 |
|
Severe Aortic Stenosis, Titration and Acute Heart Failure, Pacemakers After TAVR
|
Jun 18, 2024 |
|
Excess Apolipoprotein-B and Cardiovascular Risk, Treating Pulmonary Arterial Hypertension, SGLT2i and CV Outcomes
|
Jun 12, 2024 |
|
Anticoagulation in Post-Operative AFib, Non-ST-Elevation Acute Coronary Syndromes, Arrhythmia-Induced Cardiomyopathy
|
Jun 05, 2024 |
|
Aortic Valve Calcification and Aortic Stenosis, Microvascular Resistance Reserve After PCI, Microvascular Injury Patterns
|
May 29, 2024 |
|
Transcatheter-Based Intervention and Tetralogy of Fallot, Small Left Ventricle and Atrial Fibrillation (Afib), Aspirin Free Treatment Post-PCI
|
May 22, 2024 |
|
Guideline for the Management of Lower Extremity Peripheral Artery Disease (PAD), Decongestion Strategies for Heart Failure, Lipoproteins and Triglycerides in Cardiovascular Prevention
|
May 15, 2024 |
|
Eagle’s Eye View: The New AHA/ACC Hypertrophic Cardiomyopathy Guideline, Smoking Cessation, Embolic Stroke
|
May 08, 2024 |
|
Eagle’s Eye View: Pulsed Field Ablation and Pulmonary Vein Isolation, Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives, TAVR or SAVR and Severe Aortic Stenosis
|
May 01, 2024 |
|
Eagle’s Eye View: Cardiac Sarcoidosis, Ischemic Stroke in Women with Atrial Fibrillation, TAVR and Native Aortic Regurgitation
|
Apr 24, 2024 |
|
Eagle’s Eye View: infective Endocarditis After Invasive Dental Procedures, Serious Bleeding in Patients with Atrial Fibrillation Using Diltiazem with Apixaban or Rivaroxaban, Low-Dose Colchicine for Secondary Prevention in Atherosclerosis
|
Apr 17, 2024 |
|
Eagle’s Eye View: Introducing ACC24
|
Apr 10, 2024 |
|
Eagle’s Eye View: Day 3 -- ACCess Points Daily Wrap Up | ACC 2024
|
Apr 08, 2024 |
|
Eagle’s Eye View: Day 2 -- ACCess Points Daily Wrap Up | ACC 2024
|
Apr 07, 2024 |
|
Eagle’s Eye View: Day 1 -- ACCess Points Daily Wrap Up | ACC 2024
|
Apr 06, 2024 |
|
Eagle’s Eye View: Multivessel Revascularization, Wearable Heart Rate Monitors, Sports-Related Sudden Cardiac Death
|
Apr 03, 2024 |
|
Eagle’s Eye View: A Preview of ACC.24
|
Apr 01, 2024 |
|
Eagle’s Eye View: Sacubitril/Valsartan in Decompensated Heart Failure; Discordant Aortic Stenosis and Transcatheter Treatment of Tricuspid Valve Regurgitation
|
Mar 27, 2024 |
|
Eagle’s Eye View: Quantitative Coronary Angiography vs Intervascular Ultrasound to Guide PCI, Paclitaxel-Coated Balloon Catheters, PCI vs Coronary Artery Bypass Grafting in Left Main Disease and Diabetes
|
Mar 20, 2024 |
|
Eagle’s Eye View: Blood Pressure and PAD, Leadless Pacemakers, Palliative Care and Heart Failure
|
Mar 13, 2024 |
|
Eagle’s Eye View: Lipoprotein(a), Cardiovascular Disease, Interoperative Anemia and Sex Disparity and the Effectiveness of Surveillance Stress Testing
|
Mar 06, 2024 |
|
Eagle’s Eye View: ASCVD Risk and Diabetes, TRI-SCORE , Severe Tricuspid Regurgitation, COVID Boosters and Myocarditis
|
Feb 28, 2024 |
|
Eagle’s Eye View: Postpartum Cardiovascular Risk, Cardiac Risk and Spinal Cord Injury, Imaging and Percutaneous Coronary Intervention
|
Feb 21, 2024 |
|
Eagle’s Eye View: The AHA’s PREVENT Equations, Implantable Hemodynamic Monitors and the NOTION Trial
|
Feb 14, 2024 |
|
Eagle’s Eye View: Recovery in Peripartum Cardiomyopathy, Physical Activity and Cognitive Decline, Consumer Mobile Technologies
|
Feb 07, 2024 |
|
Eagle’s Eye View: NOAC vs. Warfarin For AFib, Sex Disparities in Medical-Guided Therapy Among HFrEF Patients, Polygenic Risk in Families With Spontaneous SCAD
|
Jan 31, 2024 |
|
Eagle’s Eye View: When DOACS Should Not Be Used as Standard Treatment, Intervention for Complex Coronary Lesions through OCT vs IVUS, Impact of Bempedoic Acid on CV Events
|
Jan 24, 2024 |
|
Eagle’s Eye View: ‘False Positive’ Exercise ECG Tests, Oral Coagulants v. Vitamin K Antagonists, Outcomes Following the Ross Procedure
|
Jan 17, 2024 |
|
Eagle’s Eye View: Artificial Intelligence in Cardiology, Arterial Thromboembolism, and the Advanced Cardiovascular Life Support (ACLS) Guidelines
|
Jan 10, 2024 |
|
Eagle’s Eye View: The Year in Cardiology: 2023 in Review
|
Dec 22, 2023 |
|
Eagle’s Eye View: What is the Importance of Residual Leaks Following Percutaneous Left Atrial Appendage Occlusion and Outcomes?
|
Dec 20, 2023 |
|
Eagle’s Eye View: What is the Safety and Tolerability of Inclisiran in Treating Hypercholesterolemia?
|
Dec 13, 2023 |
|
Eagle’s Eye View: What Are the Key Points to Remember in the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation?
|
Dec 06, 2023 |
|
Eagle’s Eye View: What Are the Cardiovascular Effects of Novel Weight Loss Therapies?
|
Nov 22, 2023 |
|
Eagle’s Eye View: What is the role of inflammation as a predictor of coronary risk?
|
Nov 15, 2023 |
|
Eagle’s Eye View: Monday, November 13 — Daily Wrap Up | AHA 2023
|
Nov 13, 2023 |
|
Eagle’s Eye View: Sunday, November 12 — Daily Wrap Up | AHA 2023
|
Nov 12, 2023 |
|
Eagle’s Eye View: Saturday, November 11 — Daily Wrap Up | AHA 2023
|
Nov 11, 2023 |
|
Eagle’s Eye View: What is the impact of residual ischemia on cardiovascular mortality in left main bifurcation stenting?
|
Nov 08, 2023 |
|
Eagle’s Eye View: AHA Scientific Sessions 2023 Preview
|
Nov 03, 2023 |
|
Eagle’s Eye View: Thursday, October 26 — ACCess Points Daily Wrap Up | TCT 2023
|
Oct 26, 2023 |
|
Eagle’s Eye View: What are the Benefits of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia?
|
Oct 25, 2023 |
|
Eagle’s Eye View: Wednesday, October 25 — ACCess Points Daily Wrap Up | TCT 2023
|
Oct 25, 2023 |
|
Eagle’s Eye View: Tuesday, October 24 — ACCess Points Daily Wrap Up | TCT 2023
|
Oct 24, 2023 |
|
Eagle’s Eye View: TCT 2023 Preview
|
Oct 21, 2023 |
|
Eagle’s Eye View: What Are the Effects of 1- vs. 3-Month DAPT?
|
Oct 18, 2023 |
|
Eagle’s Eye View: Does the Use of Remote Pulmonary Artery Pressure Monitoring With Subsequent Adjustments to Medical Treatment Reduce the Risk of Heart Failure Hospitalizations?
|
Oct 11, 2023 |
|
Eagle’s Eye View: What are the Benefits and Drawbacks of Vegetarian and Vegan Diets?
|
Oct 04, 2023 |
|
Eagle’s Eye View: Dedicated to Our Dear Friend and ACC Colleague, Steve Kerchner
|
Sep 27, 2023 |
|
Eagle’s Eye View: Can apixaban be used safely in patients with AF and end-stage kidney disease?
|
Sep 20, 2023 |
|
Eagle’s Eye View: What is the safety and efficacy of redo-TAVR?
|
Sep 13, 2023 |
|
Eagle’s Eye View: ESC Congress 2023 Follow-Up
|
Aug 31, 2023 |